Vertex Global HC Fund II Pte. Ltd. - 29 Jun 2021 Form 4 Insider Report for Elevation Oncology, Inc. (ELEV)

Role: 10%+ Owner
Signature: /s/ Wing Shing Lee, by power of attorney
Issuer symbol: ELEV
Transactions as of: 29 Jun 2021
Net transactions value: +$4,000,000
Form type: 4
Filing time: 29 Jun 2021, 16:07:21 UTC
Previous filing: 24 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELEV	Common Stock	Conversion of derivative security		+1,656,577			1,656,577	29 Jun 2021	Direct	F1
transaction	ELEV	Common Stock	Conversion of derivative security		+401,065	+24%		2,057,642	29 Jun 2021	Direct	F1
transaction	ELEV	Common Stock	Purchase	$4,000,000	+250,000	+12%	$16.00^*	2,307,642	29 Jun 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELEV	Series A Convertible Preferred Stock	Conversion of derivative security		-7,000,000	-100%		0	29 Jun 2021	Common Stock	1,656,577		Direct	F1
transaction	ELEV	Series B Convertible Preferred Stock	Conversion of derivative security		-1,694,730	-100%		0	29 Jun 2021	Common Stock	401,065		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock will automatically convert into Common Stock immediately on a 4.225582-for-one basis (4.225582 shares of preferred stock will convert into 1 share of Common Stock) prior to the closing of the Issuer's initial public offering, and has no expiration date.